Oral

[O1-5] Plantvirus/Parvovirus

Sun. Nov 13, 2022 1:50 PM - 3:20 PM Room 5 (Conference Room 109)

Chair:
Hirotaka Ebina(BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University)
Keizo Nagasaki(Kochi University)

+Add all to schedule

1:50 PM - 2:05 PM

[O1-5-1] Expression of various host specificity in an algal virus clone

*Keizo Nagasaki¹, Yusaku Funaoka¹, Haruna Hiromoto¹, Daichi Morimoto^1,3, Michiko Takahashi¹, Kei Wada² (1. Kochi University, 2. Miyazaki University, 3. JSPS)

2:05 PM - 2:20 PM

[O1-5-2] A large deletion in P1 protein of leek yellow stripe virus is a result of adaptive evolution to expand their host range.

*Shusuke Kawakubo¹, Jun Sasaki¹, Hangil Kim¹, Ok-Kyung Kim², Kazuo Yamashita³, Hanako Shimura¹, Chikara Masuta¹ (1. Graduate school of Agriculture, Hokkaido University, 2. Department of Agriculture, Faculty of Agriculture, Tokyo University of Agriculture, 3. Fukuchi Garlic R&S)

2:20 PM - 2:35 PM

[O1-5-3] Analysis of secretion of human parvovirus B19 derived virus-like particles.

*Kotaro Ishida^1,2, Takafumi Noguchi^3,4, Hidehiko Suzuki^3,4, Sakika Kimura¹, Hirotaka Ebina^3,4, Eiji Morita¹ (1. Department of Biochemistry and Molecular Biology, Hirosaki University, 2. United Graduate School of Agricultural Sciences, Iwate University, 3. Virus vaccine group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 4. The Research Foundation for Microbial Diseases of Osaka University)

2:35 PM - 2:50 PM

[O1-5-4] Serological analysis for anti-VP2 neutralizing antibody in B19 infected individuals

*Hidehiko Suzuki^1,2, Takafumi Noguchi^1,2, Kotaro Ishida³, Kosaka Mitsuyo^1,2, Eiji Morita³, Hirotaka Ebina^1,2 (1. Virus vaccine group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University , 2. The Research Foundation for Microbial Diseases of Osaka University, 3. Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University)

2:50 PM - 3:05 PM

[O1-5-5] Development of Plasmodium vivax vaccine based on attenuated vaccinia virus and adeno-associated virus

*Daiki Okuhara¹, Yutaro Yamamoto¹, Camila Fabbri², Rina Takagi¹, Yuna Kawabata¹, Takuto Katayama¹, Hiroaki Mizukami³, Hisatoshi shida⁴, Mitsuhiro Iyori^1,5, Stefanie Lopes², Shigeto Yoshida¹ (1. Kanazawa University School of Pharmacy , 2. Institute Leônidas & Maria Deane, 3. Division of Gene Therapy, Jichi Medical University, 4. Institute for Genetic Medicine, Hokkaido University, 5. Faculty of Pharmacy, Musashino University)

3:05 PM - 3:20 PM

[O1-5-6] Novel adeno-associated virus (AAV) vector production system for gene therapy

*Kenji Ohba¹, Yoshihide Sehara¹, Tatsuji Enoki², Junichi Mineno², Keiya Ozawa^1,3, Hiroaki Mizukami¹ (1. Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, 2. CDM Center, TAKARA Bio Inc, 3. Department of Immuno-Gene & Cell Therapy (Takara Bio), Jichi Medical University)

Session information